Results 151 to 160 of about 5,386 (196)

A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA Mutation. [PDF]

open access: yesCancer Med
Fujii T   +13 more
europepmc   +1 more source

HIV drug resistance during antiretroviral therapy scale-up in Uganda, 2012-19: a population-based, longitudinal study.

open access: yesLancet Microbe
Martin MA   +19 more
europepmc   +1 more source

REDD review

2023
Meta-analysis of REDD+ impact ...
Schulz, Dario   +1 more
openaire   +1 more source

Reconsidering REDD+

2021
In Reconsidering REDD+: Authority, Power and Law in the Green Economy, Julia Dehm provides a critical analysis of how the Reducing Emissions from Deforestation and Forest Degradation (REDD+) scheme operates to reorganise social relations and to establish new forms of global authority over forests in the Global South, in ways that benefit the interests ...
openaire   +1 more source

REDD+ and biodiversity

2017
Born and raised under the umbrella of the UN Framework Convention on Climate Change (UNFCCC), the topic of reducing emission from deforestation and forest degradation (REDD ) is of undeniable relevance to the regime established by the Convention on Biological Diversity.
openaire   +1 more source

«Redde for å miste, redde for å kreve,redde for å være vanskelige»:

Tidsskriftet Norges Barnevern, 2021
Milfrid Tonheim   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy